Health

Founders of COVID Vaccine, Predict Cancer Vaccine Available By 2030

Couple behind Pfizer/BioNtech COVID-19 vaccine states that cancer vaccine may be available just a few years away.

In an interview with BBC, professor Ozlem Tureci said:

“We feel that a cure for cancer or to changing cancer patients’ lives is in our grasp,”

Her husband, professor Ugur Sahin, with whom she co-founded the German pharmaceutical company BioNTech expressed his optimism that widespread access to cancer vaccines could be possible “before 2030”.

The wife-husband duo developed BioNtech after they saw an opportunity in the emerging field of mRNA technology for the creation of personalised cancer immunotherapies.

However, when the pandemic hit, they repurposed this technology to develop the first and most potent vaccination against the COVID-19.

For your information, for many years, medical professionals have tried to develop a vaccination against cancer. Interestingly, our body can avoid cancer if the immune system trains to identify and eliminate cancer cells.

There are also other kinds of vaccines that are meant to treat people who already have cancer. For instance, prostate cancer.

mRNA technology

In the recent interview, the two professors discussed how the widespread adoption of mRNA technology. It pioneered by the development of the COVID-19 vaccine, that could speed up their work on cancer vaccine.

“What we have developed over decades for cancer vaccine development has been the tailwind for developing the COVID-19 vaccine, and now the Covid-19 vaccine and our experience in developing it gives back to our cancer work,” Tureci said, explaining that “mRNA acts as a blueprint and allows you to tell the body to produce the drug or the vaccine … and when you use mRNA as a vaccine, the mRNA is a blueprint for the ‘wanted poster’ of the enemy — in this case, cancer antigens which distinguish cancer cells from normal cells.”

In addition to that, other pharmaceutical companies, such as the manufacturer of vaccines Moderna, are developing mRNA vaccines to target certain cancers.

Source:  abc NEWS

Adib Mohd

Recent Posts

TV Sarawak Is Leveling Up, From Kuching to the World with Spotlight 25/26

Since its debut in 2020, TV Sarawak (TVS) has been rewriting what it means to… Read More

7 hours ago

Skechers Steps Up the Game with New Basketball Collection

Skechers, The Comfort Technology Company™ and a global leader in lifestyle and performance footwear, has… Read More

8 hours ago

LexisNexis Brings AI Legal Sidekick to Malaysia with Protégé

Move over Suits, the future of law just got an AI upgrade. LexisNexis has officially… Read More

8 hours ago

BJAK Turns Insurance Renewals into Rewards with RM100,000 Mega Giveaway This 10.10

Renewing insurance and road tax is often a last-minute hassle, but BJAK, Malaysia’s largest online… Read More

13 hours ago

SHANTEA Dessert Opens First Outlet at Mid Valley, Serving Malaysian Culture Through Sweet Creations Ahead of Visit Malaysia 2026

Malaysian flavors stepped into the spotlight today as SHANTEA Dessert officially opened its first outlet… Read More

13 hours ago

Energea Powers Up Malaysia with Bold Tangerine Collection and Next-Gen Hybrid-Solid State Powerbank

Energea, the lifestyle-driven power solutions and tech accessories brand, has officially introduced two groundbreaking innovations:… Read More

13 hours ago

This website uses cookies.